Back
Aurinia Pharmaceuticals Quote, Financials, Valuation and Earnings
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Sell
46
AUPH
Aurinia Pharmaceuticals
Last Price:
7.21
Seasonality Move:
24.32%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!Aurinia Pharmaceuticals Price Quote
$7.21
Aurinia Pharmaceuticals Key Stats
Sell
46
Aurinia Pharmaceuticals (AUPH)
is a Sell
Day range:
$7.03 - $7.28
52-week range:
$4.71 - $10.05
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
5.00
P/B ratio:
2.83%
Volume:
1.2M
Avg. volume:
850.8K
1-year change:
-12.39%
Market cap:
$1B
Revenue:
$175.5M
EPS:
$-0.33
How Much Does Aurinia Pharmaceuticals Make?
-
How Much Are Aurinia Pharmaceuticals's Sales Annually?
AUPH Revenues are $175.5M -
How Much Profit Does Aurinia Pharmaceuticals's Make A Year?
AUPH net income is -$78M
Is Aurinia Pharmaceuticals Growing As A Company?
-
What Is Aurinia Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.38% -
What Is Aurinia Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Aurinia Pharmaceuticals Stock Price Performance
-
Did Aurinia Pharmaceuticals Stock Go Up Last Month?
Aurinia Pharmaceuticals share price went up by 1.26% last month -
Did AUPH's Share Price Rise Over The Last Year?
AUPH share price fell by -12.39% over the past 1 year
What Is Aurinia Pharmaceuticals 52-Week High & Low?
-
What Is Aurinia Pharmaceuticals’s 52-Week High Share Price?
Aurinia Pharmaceuticals has traded as high as $10.05 over the past 52 weeks -
What Is Aurinia Pharmaceuticals’s 52-Week Low Share Price?
Aurinia Pharmaceuticals has traded as low as $4.71 over the past 52 weeks
Aurinia Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Aurinia Pharmaceuticals?
-
How Much Debt Does Aurinia Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does Aurinia Pharmaceuticals Have?
Cash and short term investments quarterly total is $330.5M -
What Is Aurinia Pharmaceuticals’s Book Value Per Share?
Book value per share is 2.55
Is Aurinia Pharmaceuticals Cash Flow Positive?
-
What Is AUPH Cash Flow From Operations?
Cash flow from operations (TTM) is -$1.7M -
What Is Aurinia Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$31.2M -
What Is Aurinia Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$15.3M
Aurinia Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
AUPH return on invested capital is -13.35% -
What Is Aurinia Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -9.35% -
What Is AUPH Return On Equity?
ROE is a measure of profitability and is -13.35%
Aurinia Pharmaceuticals Earnings Date & Stock Price
-
What Is Aurinia Pharmaceuticals's Stock Price Today?
A single share of AUPH can be purchased today for 7.21 -
What Is Aurinia Pharmaceuticals’s Stock Symbol?
Aurinia Pharmaceuticals trades on the nasdaq under the ticker symbol: AUPH -
When Is Aurinia Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Aurinia Pharmaceuticals is scheduled on November 7, 2024 -
When Is AUPH's next ex-dividend date?
Aurinia Pharmaceuticals's next ex-dividend date is July 16, 2020 -
How To Buy Aurinia Pharmaceuticals Stock?
You can buy Aurinia Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Aurinia Pharmaceuticals Competitors
-
Who Are Aurinia Pharmaceuticals's Competitors?
Below is a list of companies who compete with Aurinia Pharmaceuticals or are related in some way:
Aurinia Pharmaceuticals Dividend Yield
-
What Is AUPH Dividend Yield?
Aurinia Pharmaceuticals’s dividend yield currently is 0% -
What Is Aurinia Pharmaceuticals’s Payout Ratio?
Aurinia Pharmaceuticals’s payout ratio is 0% -
When Did Aurinia Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is November 5, 2024 -
What Is Aurinia Pharmaceuticals’s Dividend Per Share?
Aurinia Pharmaceuticals pays a dividend of $0.00 per share
Aurinia Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 20.05% |
| Revenue: | 37.83% | 4.58% |
Analyst Recommendations
| Buy Recommendations: | 3 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 9.77 |
| Upside from Last Price: | 35.53% |